with respiratory failure, 22 of whom had Pneumocystis carinii pneumonia (PCP). Sixteen patients with PCP required mechanical ventilation, and 13 (81%) died despite treatment with adjunctive corticosteroids. Other causes of respiratory failure included bacterial pneumonia, pulmonary tuberculosis, adult respiratory distress syndrome, and pulmonary Kaposi's sarcoma. Overall, 22 Data were collected on gender, race, ethnicity, HIV transmission category, CD4+ cell count, admission diagnosis, the use of mechanical ventilation, adjunctive corticosteroid treatment, nutritional status, history of antiretroviral and anti-Pneumocystis prophylaxis, and whether they survived to be discharged from the hospital. Severity of illness scores were calculated by using a modification of the acute physiology and chronic health evaluation II Severity of Disease Classification System.2' The acute physiology score was based on the sum of values assigned to 11 of the 12 physiologic variables of the APACHE II system. The Glasgow Coma Score was not calculated at the time of admission to the ICU, since most patients had an endotracheal tube in place and were sedated prior to being seen by the ICU fellow. In some cases, a nondepolarizing paralytic agent had already been given.
Statistical analysis employed the computerized statistical support of a computerized system (EPI INFO, Version 5),22 using the two-way analysis of variance. Homogeneity was assessed with the Bartlett's test of homogeneity, and where appropriate, KruskalWallis one-way analysis of variance was used. Significance was determined by a probability value less than 0.05.
This study was approved by the Institutional Review Board of Beth Israel Medical Center. Since the study protocol did not identify patients by name or influence their care, informed consent from the study subjects was waived.
RESULTS
During the 1-year study period, there were 1,550 hospital admissions for HIV-infected patients, and 199 patients (13%) had PCP. In this period, 65 (4.2%) patients were admitted to the ICU and enrolled in this study.
The characteristics of the patients admitted to the ICU are shown in Table 1 Overall, 32 (49%) of the study patients survived to the time of hospital discharge. The average length of stay in the hospital was 30 days in the group which survived and 18 days in the group that did not. The average number of days in the ICU was 4.6 among the survivors and 5.3 among those who died. The principal diagnostic categories prompting admission to the ICU are listed in Table 2 . Patients were admitted because of respiratory failure, sepsis, neurologic diseases, cardiac disease, hypotension, and drug overdose. The largest diagnostic group was composed of the 35 patients admitted because of respiratory failure, defined as a primary pulmonary disorder causing respiratory distress, tachypnea, and hypoxemia requiring mechanical ventilation delivered by endotracheal tube or face mask, or requiring fraction of inspired oxygen of 0.6 or more. The mean alveolar-arterial oxygen difference while breathing 100% 02 for patients with respiratory failure was 427 mm Hg; the mean and median ratio of PaO2 to Three patients were admitted because of hypotension, defined as a systolic blood pressure less than 80 mm Hg and oliguria. One patient with candidal esophagitis had hypotension due to esophageal bleeding, one had hemophilia with generalized bleeding complications, and one had an anaphylactoid reaction to trimethoprim-sulfamethoxazole. All three patients in this group survived to hospital discharge. Five patients were admitted because of drug overdose; the two who ingested multiple drugs did not survive. A prior history regarding antiretroviral use or anti-Pneumocystis prophylaxis was available in 60 patients. Only 22 had received these interventions; 18 received antiretroviral treatment, and 15 antiPneumocystis prophylaxis. There was no significant difference in outcome between patients who did or did not receive these therapies prior to admission.
A CD4+ cell count during hospitalization was available for 56 of 65 (86%) of the patients. Patients with respiratory failure had the lowest mean CD4+ did not receive corticosteroids died, compared with 7 of 18 patients (39%) who were treated. Improved survival with adjunctive corticosteroid therapy for the treatment of severe PCP was supported by Wachter et al,12 who compared patients with PCP and respiratory failure admitted to the ICU between 1986 and 1988 with those admitted before 1986. Mortality in the earlier period was 87%, when only 5% of the patients were treated with corticosteroids, compared with 60% mortality in the later period, when 74% of the patients received corticosteroids.
In this study, we report on 65 patients with HIV infection admitted to the ICU in 1 year. Only 22 (34%) had PCP, but PCP accounted for 63% of all cases of respiratory failure. The mortality rate for patients having PCP requiring mechanical ventilation in this series was 81%, even though adjunctive corticosteroids were used routinely. This divergence from reports of improved outcome of PCP with adjunctive corticosteroids may reflect a poorer prognosis for patients who develop respiratory failure despite antimicrobial and corticosteroid therapy. Staikowsky et a124 found an overall mortality rate of 82% in a retrospective analysis of 33 patients who required mechanical ventilation for the treatment of PCP between 1987 and 1992. Only one of the 22 patients who started mechanical ventilation after 5 days of treatment with trimethoprim-sulfamethoxazole and corticosteroids survived. In general, less severe cases of PCP are treated effectively outside the ICU with anti-Pneumocystis medication and adjunctive corticosteroids, and ICU admission is unnecessary.
We also verify a shift in the spectrum of pulmonary complications affecting patients with AIDS, since 13 of the 35 patients with respiratory failure did not have PCP. There are several possible explanations accounting for the relatively high rate of other pulmonary disorders necessitating mechanical ventilation in this series. First, the literature on intensive care of patients with AIDS focuses only on patients who meet the 1987 CDC definition of AIDS. We included all patients with HIV infection in the analysis, regardless of whether they had an AIDS-defining condition. This approach more accurately describes the types of illness that patients with HIV infection develop, including first-episode bacterial pneumonia and pulmonary tuberculosis. Furthermore, 75% of patients in this series were from minority populations, and 47% were injection drug users, groups that have higher rates of bacterial pneumonia and tuberculosis than white homosexual men.25 '26 There are few reports on the outcome of patients with HIV infection admitted to an ICU for reasons other than respiratory failure. A recent review cited only four studies that examined the indications for critical care of patients with AIDS.' The reasons for admission to ICUs in these patients were quite diverse, including sepsis and hypotension, seizures, cardiac arrhythmias, drug toxicity, suicide attempts, and neurologic disorders. This series confirms the diversity of indications for critical care in HIVinfected patients. Previously published data on the outcomes of these patients are fragmented and inconclusive, but prognoses appear to be better than for PCP and respiratory failure. In this study, 63% of the 30 patients admitted to the ICU with diagnoses other than respiratory failure were discharged from the hospital.
Nutritional status is an important predictor of ICU outcome in patients with AIDS. In a comparative study of ICU admission for HIV-infected patients in two eras, Wachter et al12 found that the only variables significantly associated with survival in a stepwise logistic regression model were intensive care in the later era and a higher serum albumin level at the time of admission. We confirm the association of a higher serum albumin level upon admission to the ICU with a better outcome. The importance of prior nutritional status on outcome is supported by the observation of a 92% mortality rate in patients who had a body weight upon admission to the ICU 10% or more below than their ideal body weight, compared with a mortality rate of 42% in those whose body weight was within or greater than 10% of ideal.
There is currently a national debate on the allocation of health-care resources, particularly for the critically ill with underlying terminal diseases. Ethical deliberations in the treatment of patients with AIDS and other terminal illnesses must consider the patient's wishes, personal necessity, and survival rates.27'28 Brown and Sprung27 emphasize that good medical ethics be based on sound knowledge and up-to-date data. Early in the epidemic, published data showed a dismal outcome in patients with respiratory failure, with less than 15% survival to discharge and nearly no survivors at 1 year. Later reports indicated a more favorable outcome, possibly due to patient selection factors, antiretroviral therapy, anti-Pneumocystis prophylaxis, and the use of adjunctive corticosteroids in severe PCP. We report a 49% overall survival rate in a group of patients with a wide variety of disease processes that led to ICU admission. To determine the value of ICU treatment for the range of critical illnesses in patients with HIV infection, current data on outcome in diverse geographic settings and demographic groups are required. This study emphasizes the need for a prospective multicenter effort to investigate the outcome of intensive care for patients with HIV infection in order to better serve their medical needs while effectively using limited health-care resources.
